Mark E. Lasbury

660 total citations
41 papers, 460 citations indexed

About

Mark E. Lasbury is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Mark E. Lasbury has authored 41 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 16 papers in Infectious Diseases and 10 papers in Organic Chemistry. Recurrent topics in Mark E. Lasbury's work include Pneumocystis jirovecii pneumonia detection and treatment (36 papers), Pneumonia and Respiratory Infections (17 papers) and Tuberculosis Research and Epidemiology (13 papers). Mark E. Lasbury is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (36 papers), Pneumonia and Respiratory Infections (17 papers) and Tuberculosis Research and Epidemiology (13 papers). Mark E. Lasbury collaborates with scholars based in United States, Taiwan and China. Mark E. Lasbury's co-authors include Pamela J. Durant, Chao‐Hung Lee, Chao-Hung Lee, Chung-Ping Liao, Marilyn S. Bartlett, Chen Zhang, Chad Ray, Scott A. Rivkees, Xing Tang and James W. Smith and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Clinical Microbiology.

In The Last Decade

Mark E. Lasbury

41 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Lasbury United States 13 287 152 123 93 47 41 460
Sally L. Orr United States 8 159 0.6× 158 1.0× 134 1.1× 302 3.2× 19 0.4× 11 499
Cecília J. G. de Almeida Brazil 9 181 0.6× 67 0.4× 200 1.6× 109 1.2× 12 0.3× 10 498
S. Raghavan United States 14 109 0.4× 136 0.9× 179 1.5× 121 1.3× 7 0.1× 33 498
Marcelle R M de Andrade Brazil 5 207 0.7× 213 1.4× 70 0.6× 80 0.9× 8 0.2× 5 335
Beak‐San Choi United Kingdom 10 210 0.7× 36 0.2× 84 0.7× 212 2.3× 23 0.5× 11 529
Andrés A. Arias Colombia 9 114 0.4× 56 0.4× 140 1.1× 311 3.3× 17 0.4× 15 508
Ingeborg Režuchová Slovakia 9 161 0.6× 26 0.2× 134 1.1× 98 1.1× 13 0.3× 29 378
Jacob J. Baker United States 9 168 0.6× 220 1.4× 267 2.2× 44 0.5× 12 0.3× 12 495
Valentina Guerrini United States 8 95 0.3× 129 0.8× 115 0.9× 78 0.8× 11 0.2× 23 347
Sunmin Park United States 6 427 1.5× 151 1.0× 164 1.3× 179 1.9× 7 0.1× 9 581

Countries citing papers authored by Mark E. Lasbury

Since Specialization
Citations

This map shows the geographic impact of Mark E. Lasbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lasbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lasbury more than expected).

Fields of papers citing papers by Mark E. Lasbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Lasbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lasbury. The network helps show where Mark E. Lasbury may publish in the future.

Co-authorship network of co-authors of Mark E. Lasbury

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Lasbury. A scholar is included among the top collaborators of Mark E. Lasbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Lasbury. Mark E. Lasbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yunlong, Xiaoling Xuei, Chung-Ping Liao, et al.. (2010). Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages. BMC Microbiology. 10(1). 103–103. 12 indexed citations
2.
Liao, Chung-Ping, Mark E. Lasbury, Pamela J. Durant, et al.. (2009). Pneumocystis Mediates Overexpression of Antizyme Inhibitor Resulting in Increased Polyamine Levels and Apoptosis in Alveolar Macrophages. Journal of Biological Chemistry. 284(12). 8174–8184. 18 indexed citations
3.
Zhang, Chen, et al.. (2008). Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia. Microbes and Infection. 10(4). 334–341. 17 indexed citations
4.
Lasbury, Mark E., et al.. (2007). Polyamine-mediated Apoptosis of Alveolar Macrophages during Pneumocystis Pneumonia. Journal of Biological Chemistry. 282(15). 11009–11020. 39 indexed citations
5.
Lasbury, Mark E., et al.. (2006). Suppression of Alveolar Macrophage Apoptosis Prolongs Survival of Rats and Mice with Pneumocystis Pneumonia. The Journal of Immunology. 176(11). 6443–6453. 40 indexed citations
6.
Lasbury, Mark E., et al.. (2006). Expression and Activation of Complement Protein and Alveolar Damage during Pneumocystis Pneumonia. Journal of Eukaryotic Microbiology. 53(s1). S136–7. 3 indexed citations
7.
Lasbury, Mark E., et al.. (2006). Inflammatory Cells are Sources of Polyamines that Induce Alveolar Macrophage to Undergo Apoptosis During Pneumocystis Pneumonia. Journal of Eukaryotic Microbiology. 53(s1). S134–5. 3 indexed citations
8.
Ray, Chad, et al.. (2006). Transforming Growth Factor‐β Activation and Signaling in the Alveolar Environment during Pneumocystis Pneumonia. Journal of Eukaryotic Microbiology. 53(s1). S127–9. 3 indexed citations
9.
Zhang, Chen, et al.. (2006). Syndecan‐1 Expression in the Lung during Pneumocystis Infection. Journal of Eukaryotic Microbiology. 53(s1). S122–3. 3 indexed citations
10.
Lasbury, Mark E., et al.. (2006). Caspase‐9 as a Target for Pneumocystis Pneumonia Therapy. Journal of Eukaryotic Microbiology. 53(s1). S138–9. 1 indexed citations
12.
Lasbury, Mark E., Pamela J. Durant, & Chao‐Hung Lee. (2003). Transtracheal Inoculation of Pneumocystis carinii in Immunocompetent Animals. Journal of Eukaryotic Microbiology. 50(s1). 643–644. 1 indexed citations
13.
Lasbury, Mark E., Pamela J. Durant, & Chao‐Hung Lee. (2003). Inducible Nitric Oxide Synthase Expression in Pneumocystis carinii Pneumonia. Journal of Eukaryotic Microbiology. 50(s1). 634–636. 1 indexed citations
14.
Lasbury, Mark E., Pamela J. Durant, & Chao‐Hung Lee. (2003). Pneumocystis carinii Cyst is Associated with Inflammation in the Host. Journal of Eukaryotic Microbiology. 50(s1). 639–640. 1 indexed citations
15.
Baumgartner, Roxanne E., Pamela J. Durant, Yvonne Van Gessel, et al.. (2002). Evidence for the requirement of T cell costimulation in the pathogenesis of natural Pneumocystis carinii pulmonary infection. Microbial Pathogenesis. 33(5). 193–201. 5 indexed citations
16.
Lasbury, Mark E., Xing Tang, Pamela J. Durant, & Chao‐Hung Lee. (2001). Effect of the Transcription Factor GATA‐2 on Phagocytic Activity of Alveolar Macrophages from Pneumocystis carinii‐Infected Hosts. Journal of Eukaryotic Microbiology. 48(s1). 158S–159S. 7 indexed citations
17.
Lasbury, Mark E., Xing Tang, Pamela J. Durant, et al.. (2001). Production and Role of Nitric Oxide in the Alveolar Immune Response to Pneumocystis carinii. Journal of Eukaryotic Microbiology. 48(s1). 165S–166S. 3 indexed citations
18.
Lasbury, Mark E., Pamela J. Durant, & Chang Hee Lee. (2001). Bronchoalveolar Lavage Fluid from Pneumocystis carinii‐Infected Rats Inhibits Phagocytosis in Normal Alveolar Macrophages. Journal of Eukaryotic Microbiology. 48(s1). 163S–164S. 3 indexed citations
19.
Rivkees, Scott A., et al.. (1995). The human A1 adenosine receptor: ligand binding properties, sites of somatic expression and chromosomal localization. Endocrine. 3(9). 623–629. 5 indexed citations
20.
Rivkees, Scott A., et al.. (1995). Identification of Domains of the Human A1 Adenosine Receptor That Are Important for Binding Receptor Subtype-selective Ligands Using Chimeric A1/A2a Adenosine Receptors. Journal of Biological Chemistry. 270(35). 20485–20490. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026